Advertisement

Topics

Companies Related to "CRISPR gene editing advances outrun regulatory oversight" [Most Relevant Company Matches] RSS

02:29 EST 25th November 2017 | BioPortfolio

Here are the most relevant search results for "CRISPR gene editing advances outrun regulatory oversight" found in our extensive corporate database of over 50,000 company records.

Showing "CRISPR gene editing advances outrun regulatory oversight" Companies 1–25 of 1,900+

Extremely Relevant

CRISPR Therapeutics

CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human genetic diseases. Its vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. CRISPR Therapeutics is a Swiss company with operations in London, UK. www.crisprtx.com ...


Intellia Therapeutics

Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development: gene editing and repair using CRISPR-Cas9 technology. Intellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a b...

Relevant

Intellia Therapeutics, Inc.

Intellia Therapeutics is a leading gene-editing company focused on the development of proprietary products utilizing the recently discovered CRISPR/Cas9 technology. Intellia intends to advance its pipeline and potentially develop a new drug class by leveraging its leading scientific and clinical development expertise and its exclusive access to one of the ...


Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics...

Repare Therapeutics Inc.

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare’s platform combines a proprietary, high-throughput, CRISPR-enabled gene editing target discovery method with high-...

DiaCarta, Inc.

DiaCarta is an innovative precision molecular diagnostic company headquartered in Richmond, California. The company has an ISO 13485-certified facility, which is used to develop, manufacture and market a range of cancer research and IVD products. DiaCarta specializes in genomic testing for biomarkers and offers clinical sample testing services in a CLIA-ce...

Recombinetics

A private company founded in 2008, Recombinetics has emerged as a global leader in proprietary gene repair and gene-editing technology. Breakthrough scientific research – including the development of TALEN technologies – has resulted in global exclusive rights in the biomedical, animal agriculture and livestock vertical markets.

English Manager Science Editing

English Manager Science Editing is an Australian business that aims to provide a fast, efficient excellent-quality English language scientific editing service using the Internet. We use experienced freelance scientific editors with diverse backgrounds. Dr. Scott Butler - Managing EditorScott completed his Ph.D. in 1995 in the Department of Theoretical Chemistry at the University of Sydney. Subsequ...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the right dose. Despite advances in the understanding of the genetic and molecular basis of disease, there are no approved gene therapy products on the market today, in part because of the unmet need for effi...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology related to gene transfer and therapy and to serve as a professional adviser to the community and to the regulatory bodies in Europe.

Beaufort, LLC

Beaufort provides strategic resourcing services for the life sciences industry. The company’s range of highly customizable services includes staffing, quality oversight, clinical research, regulatory strategy and compliance, and quality assurance. Beaufort’s recruiting and staffing services provide qualified clinical research personnel for Phase I-IV ...

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, GMP/GTP manufacturing, and regulatory compliance, as well as comprehensive scientific and technical strategic analysis of business opportunities in cell, gene and tissue therapies.

Precision BioSciences Inc.

Precision BioSciences’ mission is to continually provide, improve, and enable the world’s most powerful genome engineering technology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or plant ce...

Precision BioSciences, Inc.

Precision's mission is to utilize its engineered endonuclease technology to become the world leader in the field of genomic molecular biology. Precision’s proprietary Directed Nuclease EditorTM (DNE) technology enables the production of custom genome editing enzymes that can insert, remove, modify, and regulate essentially any gene in mammalian or pla...

Caribou Biosciences, Inc.

Caribou is a leading company in CRISPR genome engineering founded by pioneers of CRISPR-Cas9 biology based on research carried out in the Doudna Laboratory at the University of California, Berkeley. Caribou’s tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and...

GSK, Merck Sharp & Dohme (MSD), and the MECTIZAN® Donation Program (MDP)

The MECTIZAN® Donation Program (MDP) was established in 1987 to provide medical, technical and administrative oversight of the donation of MECTIZAN® by MSD for the treatment of onchocerciasis. In 1998, MDP expanded its mandate to include oversight of the donation of albendazole by GSK for the elimination of lymphatic filariasis in onchocerciasis co-e...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

American Society of Gene Therapy

The American Society of Gene Therapy (ASGT) is a non-profit medical and professional organization that represents researchers and scientists devoted to the discovery of new gene therapies. ASGT was established in 1996 by Dr. George Stamatoyannopoulos, professor of medicine at the University of Washington 's School of Medicine and a group of the country's leading researchers in gene therapy. With m...

Taratec

Taratec is an industry-leading consultancy that provides regulatory compliance and systems lifecycle services to address the unique business and information technology challenges faced by life science companies. Our clients are the leading innovators in the pharmaceutical, biotechnology, and medical device industries.Life science companies are aggressively investing to achieve the tremendous benef...

Genomatix Software GmbH

Genomatix is a privately held company located in Munich, Germany. We offer software, databases and services aimed at understanding gene regulation at the molecular level.Gene regulation is the basic principle ruling any subsequent metabolic pathways, signaling cascades and their interweaving into biological networks of a living cell. Any expression profile observed by a micro array experiment is d...

WuXi AppTec

WuXi AppTec’s U.S. Manufacturing and Testing group provides a comprehensive range of integrated programs for biologics, advanced therapies and medical devices – along with expert technical and regulatory guidance – to help take products from preclinical development to commercialization and beyond. Facilities – located in Philadelphia, S...

Infigen Incorporated

Our Heritage Infigen was formed in late 1997, following the introduction of “Gene,” the world’s first bovine cloned from a non-embryo-derived cell. Prior to that time, Infigen was part of ABS Global, Inc. Our Resources Our team of elite scientists utilize state-of-the-art laboratories, technology and bio-secure livestock facilities. Through alliances with commercial and academic laboratories...

PhenomicDB

PhenomicDB is a multi-organism phenotype-genotype database including human, mouse, fruit fly, C.elegans, and other model organisms. The inclusion of gene indeces (NCBI Gene) and orthologues (same gene in different organisms) from HomoloGene allows to compare phenotypes of a given gene over many organisms simultaneously. PhenomicDB contains data from publicly available primary databases: FlyBase, F...

Gene Smart

Gene Smart Wellness is a preventative healthcare company dedicated to pioneering real world approaches that empower individuals to take control of their whole health in order to live abundantly. The company's innovations include its Living Abundantly Community Wellness Program, the Gene Smart Omega-3 Index Home Blood Test and the Gene Smart Anti-Inflammation Diet & Exercise Program. More informati...

SwitchGear Genomics Inc.

SwitchGear Genomics Inc. is a leading provider of innovative products for studying gene regulation in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory networks, allowing researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Mye...


More From BioPortfolio on "CRISPR gene editing advances outrun regulatory oversight"

Quick Search
Advertisement
 

Corporate Database Quicklinks